Wednesday, March 22, 2023 11:49:43 AM
Nonsense, big pharma has lost trillions of dollars in failed drug trials.
$RVVTF is still in the fight and 7 years closer to an approval on a record breaking phase III trial that the market has ever seen on a small start start up sized firm in this sector.
$RVVTF is still in the fight and 7 years closer to an approval on a record breaking phase III trial that the market has ever seen on a small start start up sized firm in this sector.
Bullish
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
